Net shares · 365d
-5.7K
0 buy · 5.7K sell
Net value · 365d
-$20.0K
$0 in · $20.0K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
4
0 buy · 5.7K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
GNLX Sell·S
Chief Scientific Officer
$1.8K
605 sh · $2.97
Own -0%
-
GNLX Sell·S
SVP, Clinical Development
$2.2K
906 sh · $2.42
Own -1%
-
GNLX Sell·S
SVP, Clinical Development
$16.0K
4.2K sh · $3.83 avg · 2 lots
Own -3%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| May 11, 2026 | GNLX | Sell S | 605 | $1.8K |
| Mar 24, 2026 | GNLX | Sell S | 906 | $2.2K |
| Nov 17, 2025 | GNLX | Sell S | 4.2K2 lots | $16.0K |
Buy Sell Non-market (grant · exercise · gift)
About Yu Tony
This profile aggregates every SEC Form 4 insider transaction reported by Yu Tony across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.